DHA Pharmacist Drug Interactions and Safety

Question 1

What is serotonin syndrome and which drug combinations increase its risk?

Accepted Answer

A potentially life-threatening condition caused by excess serotonin from combinations like SSRIs with tramadol, MAOIs, or triptans

Answer

Serotonin syndrome results from excessive serotonergic activity, commonly triggered by combining SSRIs/SNRIs with MAOIs, tramadol, triptans, or linezolid, presenting with agitation, hyperthermia, and neuromuscular changes.

Question 2

What is the QT prolongation risk that DHA pharmacists must screen for?

Accepted Answer

Certain medications (macrolides, fluoroquinolones, antipsychotics, antiemetics) can prolong the QT interval, risking fatal cardiac arrhythmias

Answer

DHA pharmacists must screen for QT-prolonging drug combinations including macrolides (azithromycin), fluoroquinolones (moxifloxacin), antipsychotics (haloperidol), and antiemetics (ondansetron), especially in patients with risk factors.

Question 3

What are the key drug-food interactions DHA pharmacists must counsel patients about?

Accepted Answer

Grapefruit with statins/CCBs, dairy with fluoroquinolones/tetracyclines, vitamin K-rich foods with warfarin, and tyramine-rich foods with MAOIs

Answer

Key drug-food interactions include grapefruit inhibiting CYP3A4 (affecting statins, CCBs), dairy chelating antibiotics, vitamin K-rich foods opposing warfarin, and tyramine-containing foods causing hypertensive crisis with MAOIs.

Question 4

What is the clinical significance of CYP450 enzyme interactions for DHA pharmacists?

Accepted Answer

CYP450 enzyme inhibition or induction can significantly alter drug levels, causing toxicity or therapeutic failure

Answer

CYP450 enzyme interactions are clinically critical: inhibitors (ketoconazole, erythromycin) increase drug levels risking toxicity, while inducers (rifampicin, carbamazepine) decrease levels causing therapeutic failure.

Question 5

What is the pharmacist's role in preventing adverse drug reactions (ADRs) in Dubai?

Accepted Answer

Screen prescriptions for interactions, assess patient risk factors, adjust doses for renal/hepatic impairment, and monitor for early ADR signs

Answer

DHA pharmacists prevent ADRs through proactive screening of prescriptions for interactions and contraindications, assessing individual risk factors, recommending dose adjustments, and educating patients on warning signs.

DHA Pharmacist Practice Test

DHA Pharmacist Practice Test

DHA Pharmacist Drug Interactions and Safety